retatrutide phase 2 trial new england journal of medicine approval: FDA status, clinical results, and when it could be available A Placebo Controlled Evaluation of

This eliminates surprise charges and makes budgeting for treatment straightforward

By contrast, countries like India, which do not award patent term extensions, could see generic competition entering much sooner once the patents on the main compound expire there in 2026

If you're pregnant, breastfeeding, have a medical condition, or are taking prescription medications, consult your healthcare provider before use

Second, we did not assess adherence to medication in the sample

The right pathway depends on the persons health profile and treatment goals

Screening for depression, anxiety, and eating disorders should occur regularly, as these conditions may contribute to weight regain and affect treatment response